Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer

Breast Cancer Research and Treatment
Seth RummelRachel E Ellsworth

Abstract

Although breast cancer in young women accounts for <10% of diagnoses annually, tumors in young patients exhibit more aggressive characteristics and higher mortality rates. Determination of the frequency of germline mutations in cancer predisposition genes is needed to improve the understanding of breast cancer etiology in young women. All female patients enrolled in the Clinical Breast Cancer Project between 2001 and 2015 and diagnosed with invasive breast cancer before age 40 were included in this study. Family history was classified using the NCCN Familial Risk Assessment guidelines. Targeted sequencing of 94 cancer predisposition genes was performed using peripheral blood DNA. Variants were detected using VariantStudio and classified using ClinVar. Seven percent (141/1980) of patients were young women and 44 had a significant family history. Sequencing was completed for 118 women with genomic DNA. Pathogenic mutations were present in 27 patients: BRCA1 (n = 10), BRCA2 (n = 12), TP53 (n = 1), and CHEK2 (n = 4). Mutations classified as pathogenic were also detected in APC (n = 1) and MUTYH (n = 2). Variants of uncertain significance (VUS) were detected in an additional 17 patients in ten genes. Pathogenic mutations in high- an...Continue Reading

References

May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A J NixonJ R Harris
Jan 18, 1996·The New England Journal of Medicine·A A LangstonE A Ostrander
Jan 18, 1996·The New England Journal of Medicine·M G FitzGeraldD A Haber
Apr 18, 2001·International Journal of Cancer. Journal International Du Cancer·P N ToninP Ghadirian
Jan 22, 2002·International Journal of Cancer. Journal International Du Cancer·A Meindl, UNKNOWN German Consortium for Hereditary Breast and Ovarian Cancer
May 17, 2003·Cancer Causes & Control : CCC·Michelle D AlthuisLouise A Brinton
Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Silvia de SanjoséOlga M Sinilnikova
Jan 30, 2007·The Breast : Official Journal of the European Society of Mastology·Antonino MusolinoAndrea Ardizzoni
Nov 13, 2008·Journal of the National Cancer Institute·Louise A BrintonWilliam F Anderson
Apr 21, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Elizabeth H HammondAntonio C Wolff
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Apr 16, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allison W KurianJames M Ford
Jul 19, 2014·Clinical Breast Cancer·Hanan Gewefel, Bodour Salhia
Nov 28, 2014·Breast Cancer Research and Treatment·Jane E ChurpekOlufunmilayo I Olopade
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fergus J CouchPeter A Fasching
Aug 19, 2015·Ecancermedicalscience·Krizia FerriniLucilla Titta
Mar 16, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nadine TungJudy E Garber

❮ Previous
Next ❯

Citations

Sep 23, 2020·Molecular Genetics & Genomic Medicine·Jeanne P UyisengaVincent Bours
Oct 12, 2021·International Journal of Clinical Oncology·Tadashi KumamotoYukiko Tsunematsu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.